CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions - Episode 2

CRESTONE Trial of Seribantumab in NRG1+ Solid Tumors: Efficacy Data

,

Shared insight on key efficacy data from the CRESTONE clinical trial of seribantumab therapy in patients with NRG1+ solid tumors.